Methcathinone

DB15339ExperimentalSmall molecule

Methcathinone is under investigation in clinical trial NCT02617862 (PCI Imaging System in Pediatric Ophthalmology).

Mechanism: Pharmacologically active on Sodium-dependent noradrenaline transporter, Sodium-dependent dopamine transporter, and Sodium-dependent serotonin transporter
Curator reviewed
Formula / weight: C₁₀H₁₃NO · 163.2163 g/mol (avg)
Also known as: COSMOS

Resolves to

Compound

Structure

InChIKeyLPLLVINFLBSFRP-UHFFFAOYSA-NSMILESCNC(C)C(=O)C1=CC=CC=C1

Targets

What you can answer from here — as of July 08, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Methcathinone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.